|
Transplantation
Citations 211-220 of 1455 total displayed.
|
Past content
(since Jan 1997):
|
Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation
- Jason W. Chien, Michael J. Boeckh, John A. Hansen, and Joan G. Clark
Blood 2008; 111: 2462-2469.
[Abstract]
[Full text]
[PDF]
Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease
- John E. Levine, Sophie Paczesny, Shin Mineishi, Thomas Braun, Sung W. Choi, Raymond J. Hutchinson, Dawn Jones, Yasser Khaled, Carrie L. Kitko, Daniel Bickley, Oleg Krijanovski, Pavan Reddy, Gregory Yanik, and James L. M. Ferrara
Blood 2008; 111: 2470-2475.
[Abstract]
[Full text]
[PDF]
Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease
- Hong Zheng, Catherine Matte-Martone, Hongmei Li, Britt E. Anderson, Srividhya Venketesan, Hung Sheng Tan, Dhanpat Jain, Jennifer McNiff, and Warren D. Shlomchik
Blood 2008; 111: 2476-2484.
[Abstract]
[Full text]
[PDF]
Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years
- Karen L. Syrjala, Brenda F. Kurland, Janet R. Abrams, Jean E. Sanders, and Julia R. Heiman
Blood 2008; 111: 989-996.
[Abstract]
[Full text]
[PDF]
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice
- Pascale V. Guillot, Oyebode Abass, J. H. Duncan Bassett, Sandra J. Shefelbine, George Bou-Gharios, Jerry Chan, Hitoshi Kurata, Graham R. Williams, Julia Polak, and Nicholas M. Fisk
Blood 2008; 111: 1717-1725.
[Abstract]
[Full text]
[PDF]
Characterization of in vitro antimurine thymocyte globulin–induced regulatory T cells that inhibit graft-versus-host disease in vivo
- Melanie C. Ruzek, James S. Waire, Deborah Hopkins, Gina LaCorcia, Jennifer Sullivan, Bruce L. Roberts, Susan M. Richards, Sharon R. Nahill, John M. Williams, Abraham Scaria, John Dzuris, Srinivas Shankara, and Richard D. Garman
Blood 2008; 111: 1726-1734.
[Abstract]
[Full text]
[PDF]
Clinical stem-cell sources contain CD8+CD3+ T-cell receptor–negative cells that facilitate bone marrow repopulation with hematopoietic stem cells
- Stephanie Bridenbaugh, Linda Kenins, Emilie Bouliong-Pillai, Christian P. Kalberer, Elena Shklovskaya, Alois Gratwohl, and Aleksandra Wodnar-Filipowicz
Blood 2008; 111: 1735-1738.
[Abstract]
[Full text]
[PDF]
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party
- Debra L. Friedman, Alicia Rovo, Wendy Leisenring, Anna Locasciulli, Mary E. D. Flowers, Andre Tichelli, Jean E. Sanders, H. Joachim Deeg, and Gerard Socie
Blood 2008; 111: 939-944.
[Abstract]
[Full text]
[PDF]
The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation
- Vu H. Nguyen, Sumana Shashidhar, Daisy S. Chang, Lena Ho, Neeraja Kambham, Michael Bachmann, Janice M. Brown, and Robert S. Negrin
Blood 2008; 111: 945-953.
[Abstract]
[Full text]
[PDF]
β2 integrins separate graft-versus-host disease and graft-versus-leukemia effects
- Yaming Liang, Chen Liu, Julie Y. Djeu, Bin Zhong, Thorsten Peters, Karin Scharffetter-Kochanek, Claudio Anasetti, and Xue-Zhong Yu
Blood 2008; 111: 954-962.
[Abstract]
[Full text]
[PDF]
|
|
